POLARISqb, Auransa Report Using Quantum Computers to Identify Promising Treatment Targets for Triple Negative Breast Cancer

Insider Brief Triple-negative breast cancer is an aggressive cancer, accounting for about 15% of breast cancers, with fewer treatment options and often worse outcome. Auransa, Inc. and Polaris Quantum Biotech used their combined artificial intelligence and quantum computing tools to a identify biological pathway that is predicted to be relevant and within this pathway, the companies […]